Court dismisses Bayer’s appeal on timing of patent and retroactive eligibility

By Anosha Khan ( August 11, 2025, 5:19 PM EDT) -- The Federal Court of Appeal has dismissed an appeal by pharmaceutical manufacturer Bayer regarding a subsequent entry version of the drug aflibercept by a competitor that did not cite the appellant’s patent despite being filed first....